Gerresheimer AG Logo

Gerresheimer AG

GXI | F

Overview

Corporate Details

ISIN(s):
DE000A0LD6E6
LEI:
5299006GD4UWSYZOKC28
Country:
Germany
Address:
Klaus-Bungert-Straße 4, 40468 Düsseldorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Gerresheimer AG is a global partner and solutions provider specializing in primary packaging and drug delivery systems for the pharmaceutical, biotech, and cosmetics industries. The company develops and manufactures a broad portfolio of high-quality glass and plastic products, including pharmaceutical vials, syringes, ampoules, cartridges, and containers. It also offers integrated solutions for drug delivery devices, such as inhalers and auto-injectors, acting as a full-service partner from concept development to the finished product. Additionally, Gerresheimer provides packaging for the perfume and personal care sectors and serves as a supplier for diagnostic and medical device components.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Gerresheimer AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-25 14:47
Declaration of Voting Results & Voting Rights Announcements
English 16.3 KB
2025-08-22 10:46
Declaration of Voting Results & Voting Rights Announcements
English 15.4 KB
2025-08-21 09:28
Declaration of Voting Results & Voting Rights Announcements
English 19.4 KB
2025-08-19 15:16
Declaration of Voting Results & Voting Rights Announcements
English 15.8 KB
2025-08-14 09:31
Declaration of Voting Results & Voting Rights Announcements
English 14.6 KB
2025-08-13 08:44
Declaration of Voting Results & Voting Rights Announcements
English 19.4 KB
2025-08-12 08:00
Board/Management Information
Gerresheimer AG: Achim Schalk To Join the Gerresheimer Management Board
English 10.4 KB
2025-08-11 08:58
Major Shareholding Notification
English 15.7 KB
2025-08-08 11:56
Major Shareholding Notification
English 15.8 KB
2025-08-07 09:38
Declaration of Voting Results & Voting Rights Announcements
English 19.4 KB
2025-08-05 10:41
Declaration of Voting Results & Voting Rights Announcements
English 16.2 KB
2025-08-04 18:40
Regulatory News Service
Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sal…
English 11.8 KB
2025-07-31 10:48
Declaration of Voting Results & Voting Rights Announcements
English 15.4 KB
2025-07-28 11:07
Major Shareholding Notification
English 19.4 KB
2025-07-23 13:07
Declaration of Voting Results & Voting Rights Announcements
English 19.4 KB

Automate Your Workflow. Get a real-time feed of all Gerresheimer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Gerresheimer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-13 Siemssen, Dietmar Board Buy None 74,994.10 EUR
2022-10-14 Siemssen, Dietmar Board Buy None 137,500.00 EUR
2022-10-14 Simon-Schröter, Dr Wolfram Other Buy None 2,958.00 EUR
2022-09-19 Abt, Andrea Supervisory board Buy None 25,075.00 EUR
2022-09-19 Empl, Andreas Board Buy None 1,820.00 EUR
2022-07-18 Siemssen, Dietmar Board Buy None 151,730.25 EUR
2021-07-14 Burkhardt, Dr. Lukas Board Buy None 181,357.60 EUR
2021-07-14 Siemssen, Dietmar Board Buy None 139,732.50 EUR

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN